Volume 55, Issue 10 pp. 923-930

Ash (Fraxinus excelsior)-pollen allergy in central Europe:specific role of pollen panallergens and the major allergen of ash pollen, Fra e 1

W. Hemmer

W. Hemmer

Dermatologic and Pediatric Allergy Clinic, Vienna

Search for more papers by this author
M. Focke

M. Focke

Dermatologic and Pediatric Allergy Clinic, Vienna

Search for more papers by this author
F. Wantke

F. Wantke

Dermatologic and Pediatric Allergy Clinic, Vienna

Search for more papers by this author
M. Götz

M. Götz

Dermatologic and Pediatric Allergy Clinic, Vienna

Search for more papers by this author
R. Jarisch

R. Jarisch

Dermatologic and Pediatric Allergy Clinic, Vienna

Search for more papers by this author
S. Jäger

S. Jäger

ENT Department, University of Vienna

Search for more papers by this author
M. Götz

M. Götz

Department of Pediatrics, Wilhelminenspital, Vienna, Austria

Search for more papers by this author
First published: 24 December 2001
Citations: 59
Wolfgang Hemmer, PhD, Dermatologic and Pediatric Allergy Clinic
Franz Jonas Platz 8/6
A-1210 Vienna
Austria

Abstract

Background: The role of ash (Fraxinus excelsior) pollen as a cause of spring pollinosis in central Europe has received little attention. It is not clear whether ash pollen is a primary cause of sensitization or whether it is implicated through cross-sensitization to other pollens.

Methods: Over a 22-month period, ash pollen was included in a screening series for inhalant allergies. Pollen data were documented from 1976 through 1999. The frequency of IgE-binding to the ash-specific allergen Fra e 1 and pollen panallergens, respectively, was compared by Western blot between mono- (n=6), oligo- (n=16), and polysensitized (n=25) patients.

Results: Of 5416 consecutive patients sensitized to any pollen, 920 (17.6%) had a positive skin prick test to ash. Total pollen counts varied extensively between years (229–5351) as did peak concentrations (23–837 grains/m3/24 h). Western blotting revealed Fra e 1 sensitization in 100% of monosensitized, 93% of oligosensitized, but only 44% of polysensitized patients. IgE against profilins (Fra e 2), Ca-binding proteins (Fra e 3), and carbohydrate epitopes in the three groups was found in 0/0/17%, 0/19/31%, and 32/72/60%, respectively. At least 50% of sera from patients with Fra e 1 sensitization did not bind with the protein in Western blots under reducing conditions.

Conclusions: Ash pollen should be considered a relevant factor and distinct entity in spring pollinosis. In all, only 20% of positive skin tests to ash appear to result from cross-sensitization to pollen panallergens.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.